Weight Nicholas, Singh Sandeep, Moledina Saadiq, Mamas Mamas A
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, United Kingdom.
Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, United Kingdom; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK.
Int J Cardiol. 2025 Jan 15;419:132669. doi: 10.1016/j.ijcard.2024.132669. Epub 2024 Oct 22.
Acute myocardial infarction with cardiogenic shock (AMI-CS) carries a significant risk of inpatient mortality compared with AMI alone, although it is unclear what the longer-term outcomes of AMI-CS survivors is, and whether the inpatient quality of care received influences this.
Using the Myocardial Ischaemia National Audit Project (MINAP) registry, linked to Office for National Statistics (ONS) mortality data, we analyzed 330,517 UK AMI patients; 3330 (1 %) with CS. Patients dying within thirty-days of admission were excluded. Median follow-up for patients included was 1642 days. Cox regression models were fitted, adjusting for demographics and management strategy.
AMI-CS survivors were younger (median years) (67 vs. 69, p < 0.001), less often female (29 % vs. 32 %, p < 0.001) and more likely to present with STEMI (81 % vs. 37 %, p < 0.001). Mortality risk was highest at one-year for AMI-CS survivors compared to patients that did not suffer CS (adjusted hazard ratio [HR] 1.85; 95 % CI; 1.68-2.04, p < 0.001), and remained elevated at five-years (HR 1.55; 95 % CI; 1.43-1.68, p < 0.001). 'Excellent-care' according to mean opportunity-based quality indicator (OBQI) score compared to 'Poor-care', showed reduced risk of long-term mortality with AMI-CS (HR: 0.46, CI; 0.39-0.54, P < 0.001). Of patients that received "Excellent-care", AMI-CS survivors had elevated risk of long-term mortality (HR 1.45, 95 % CI; 1.34-1.57, P < 0.001).
AMI-CS survivors have elevated risk long-term mortality risk when compared with AMI patients, which persists beyond five years. AMI-CS patients that receive higher-quality inpatient care have better longer-term survival compared to those with poorer inpatient care.
与单纯急性心肌梗死(AMI)相比,急性心肌梗死合并心源性休克(AMI-CS)患者住院期间死亡风险显著增加,不过目前尚不清楚AMI-CS幸存者的长期预后情况,以及住院期间所接受的医疗质量是否会对此产生影响。
利用与英国国家统计局(ONS)死亡率数据相关联的心肌缺血国家审计项目(MINAP)登记系统,我们分析了330517例英国AMI患者;其中3330例(1%)合并CS。排除入院后30天内死亡的患者。纳入患者的中位随访时间为1642天。采用Cox回归模型,并对人口统计学和治疗策略进行了校正。
AMI-CS幸存者更年轻(中位年龄)(67岁对69岁,p<0.001),女性比例更低(29%对32%,p<0.001),更易表现为ST段抬高型心肌梗死(STEMI)(81%对37%,p<0.